Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 4561 AL 4575

Good, bad, and neglectful: Astrocyte changes in neurodegenerative disease

Jiwaji Z, Hardingham GE.

Free Radic Biol Med. 2022 Mar;182:93-99. doi: 10.1016/j.freeradbiomed.2022.02.020. Epub 2022 Feb 22.

Sphingosine kinase-dependent regulation of pro-resolving lipid mediators in Alzheimer's disease

Ayub M, Jin HK, Bae JS.

Biochim Biophys Acta Mol Cell Biol Lipids. 2022 May;1867(5):159126. doi: 10.1016/j.bbalip.2022.159126. Epub 2022 Feb 21.

How do protein aggregates escape quality control in neurodegeneration?

Koopman MB, Ferrari L, Rüdiger SGD.

Trends Neurosci. 2022 Apr;45(4):257-271. doi: 10.1016/j.tins.2022.01.006. Epub 2022 Feb 21.

Effect of metal ions on Alzheimer's disease

Liu F, Zhang Z, Zhang L, Meng RN, Gao J, Jin M, Li M, Wang XP.

Brain Behav. 2022 Mar;12(3):e2527. doi: 10.1002/brb3.2527. Epub 2022 Feb 24.

Gut Microbiota as a Hidden Player in the Pathogenesis of Alzheimer's Disease

Choi H, Lee D, Mook-Jung I.

J Alzheimers Dis. 2022;86(4):1501-1526. doi: 10.3233/JAD-215235.

Comprehensive Review Regarding Mercury Poisoning and Its Complex Involvement in Alzheimer's Disease

Paduraru E, Iacob D, Rarinca V, Rusu A, Jijie R, Ilie OD, Ciobica A, Nicoara M, Doroftei B.

Int J Mol Sci. 2022 Feb 11;23(4):1992. doi: 10.3390/ijms23041992.

Aging, Cellular Senescence, and Alzheimer's Disease

Liu RM.

Int J Mol Sci. 2022 Feb 11;23(4):1989. doi: 10.3390/ijms23041989.

Platelet-derived growth factor signalling in neurovascular function and disease

Li SY, Johnson R, Smyth LC, Dragunow M.

Int J Biochem Cell Biol. 2022 Apr;145:106187. doi: 10.1016/j.biocel.2022.106187. Epub 2022 Feb 23.

Promising heterocycle-based scaffolds in recent (2019-2021) anti-Alzheimer's drug design and discovery

Dorababu A.

Eur J Pharmacol. 2022 Apr 5;920:174847. doi: 10.1016/j.ejphar.2022.174847. Epub 2022 Feb 23.

mTOR signaling as a molecular target for the alleviation of Alzheimer's disease pathogenesis

Rapaka D, Bitra VR, Challa SR, Adiukwu PC.

Neurochem Int. 2022 May;155:105311. doi: 10.1016/j.neuint.2022.105311. Epub 2022 Feb 23.

Mitochondrial ribosomal protein genes connected with Alzheimer's and tellurite toxicity

Del Giudice L, Alifano P, Calcagnile M, Di Schiavi E, Bertapelle C, Aletta M, Pontieri P.

Mitochondrion. 2022 May;64:45-58. doi: 10.1016/j.mito.2022.02.006. Epub 2022 Feb 24.

Therapeutic strategies for tauopathies and drug repurposing as a potential approach

Islam M, Shen F, Regmi D, Du D.

Biochem Pharmacol. 2022 Apr;198:114979. doi: 10.1016/j.bcp.2022.114979. Epub 2022 Feb 24.

Simulated Electroconvulsive Therapy: A Novel Approach to a Control Group in Clinical Trials

McManus KR, Lapid MI, Forester BP, Mueller M, Hermida AP, Nykamp L, Harper DG, Seiner SJ, Sanghani S, Patrick R, Gentry MT, Kung S, Leal JC, Johnson EK, Petrides G.

J ECT. 2022 Sep 1;38(3):165-170. doi: 10.1097/YCT.0000000000000832. Epub 2022 Mar 1.

How nano-engineered delivery systems can help marketed and repurposed drugs in Alzheimer's disease treatment?

Séguy L, Groo AC, Malzert-Fréon A.

Drug Discov Today. 2022 Jun;27(6):1575-1589. doi: 10.1016/j.drudis.2022.02.022. Epub 2022 Feb 25.

Impaired insulin signalling and allostatic load in Alzheimer disease

De Felice FG, Gonçalves RA, Ferreira ST.

Nat Rev Neurosci. 2022 Apr;23(4):215-230. doi: 10.1038/s41583-022-00558-9. Epub 2022 Feb 28.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias